4 completed, 2 recruiting, 2 terminated, 1 unknown. 9 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 4, Recruiting 2, Terminated 2, Unknown 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Interferons: new trials by email Literature Review of Interferons trials Research Report on Interferons
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis Interferon, Sodium Hyaluronate, Sodium Chloride Injection - Interstitial Cystitis | Phase 2 / Phase 3 | Unknown | West China Hospital | 129 | 2023-10-15 | 2023-09-15 |
| Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia Interferon - Acute Myeloid Leukemia | Phase 3 | Recruiting | Peking University People's Hospital | 96 | 2023-01-01 | 2025-01-31 |
| Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS Ofatumumab, First line DMT - Multiple Sclerosis | Phase 3 | Completed | Novartis Pharmaceuticals | 185 | 2021-07-23 | 2026-03-03 |
| MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera Ruxolitinib, Hydroxycarbamide, Interferon-Alpha - Polycythemia Vera | Phase 3 | Recruiting | University of Birmingham | 586 | 2019-10-25 | 2026-10-26 |
| Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer CG0070 Adenovirus Vector, Control Arm: Quadruple Choice - Transitional Cell Carcinoma, Bladder Cancer | Phase 2 / Phase 3 | Terminated | CG Oncology, Inc. | 22 | 2014-03-01 | 2021-04-14 |
| Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma Capecitabine, Interferon, Interleukin - Renal Cell Cancer | Phase 3 | Terminated | Central European Cooperative Oncology Group | 172 | 2004-03-01 | 2012-05-16 |
| Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients Fludarabine, Novantrone, Decadron - Lymphoma | Phase 3 | Completed | M.D. Anderson Cancer Center | 210 | 1998-03-16 | 2020-11-16 |
| Randomized Study for Patients With Follicular Lymphoma Needing Treatment CHVP + interferon, fludarabine, CHOP + TBI and autotransplant - Follicular Lymphoma | Phase 3 | Completed | Lymphoma Study Association | 400 | 1994-01-01 | 2005-09-01 |
| Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C 5-fluorouracil, levamisol, interferon - Colon Cancer Stage III | Phase 3 | Completed | Austrian Breast & Colorectal Cancer Study Group | 598 | 1990-10-01 | 2006-04-03 |
Lymphoma, Follicular (2) · Adenoviridae Infections (1) · Carcinoma in Situ (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Colonic Neoplasms (1) · Cystitis, Interstitial (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Multiple Sclerosis (1) · Neoplasms (1) · Polycythemia Vera (1) · Urinary Bladder Neoplasms (1) · Virus Diseases (1)
Austrian Breast & Colorectal Cancer Study Group (1) · CG Oncology, Inc. (1) · Central European Cooperative Oncology Group (1) · Lymphoma Study Association (1) · M.D. Anderson Cancer Center (1) · Novartis Pharmaceuticals (1) · Peking University People's Hospital (1) · University of Birmingham (1) · West China Hospital (1)
Austria (2) · France (2) · United States (2) · Belgium (1) · China (1) · Germany (1) · Italy (1) · Spain (1) · United Kingdom (1)
Alex W Yeung, MBBS (1) · Bertrand Coiffier, MD (1) · Catherine Sebban, MD (1) · Claire Harrison (1) · Jean-Jacques Kiladjian (1) · Manuela Schmidinger, Prof (1) · Nathan Fowler, MD (1) · Raimund Jakesz, MD (1) · Wei-min Li (1)